{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T00:32:55Z","timestamp":1791765175339,"version":"4.3.4"},"reference-count":135,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003977","name":"Israel Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003977","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular and Cellular Endocrinology"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.mce.2020.111003","type":"journal-article","created":{"date-parts":[[2020,9,9]],"date-time":"2020-09-09T21:21:17Z","timestamp":1599686477000},"page":"111003","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":45,"special_numbering":"C","title":["Role of the GH-IGF1 system in progression of cancer"],"prefix":"10.1016","volume":"518","author":[{"given":"Haim","family":"Werner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zvi","family":"Laron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.mce.2020.111003_bib1","first-page":"505","article-title":"The founder mutations 185delAG and 5382insC in BRCA1 and 6174delT in BRCA2 appear in 60% of ovarian cancer and 30% of early-onset breast cancer patients among Ashkenazi women","volume":"60","author":"Abeliovich","year":"1997","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.mce.2020.111003_bib2","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0014-5793(03)00315-6","article-title":"BRCA1-Sp1 interactions in transcriptional regulation of the IGF-IR gene","volume":"541","author":"Abramovitch","year":"2003","journal-title":"FEBS Lett."},{"key":"10.1016\/j.mce.2020.111003_bib3","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1055\/s-2004-814154","article-title":"Functional and physical interactions between BRCA1 and p53 in transcriptional regulation of the IGF-IR gene","volume":"35","author":"Abramovitch","year":"2003","journal-title":"Horm. Metab. Res."},{"key":"10.1016\/j.mce.2020.111003_bib4","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1056\/NEJMoa010107","article-title":"IGF-I receptor mutations resulting in intrauterine and postnatal growth retardation","volume":"349","author":"Abuzzahab","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.mce.2020.111003_bib5","doi-asserted-by":"crossref","first-page":"4437","DOI":"10.18632\/oncotarget.27055","article-title":"Identification of ZYG11A as a candidate IGF1-dependent proto-oncogene in endometrial cancer","volume":"10","author":"Achlaug","year":"2019","journal-title":"Oncotarget"},{"key":"10.1016\/j.mce.2020.111003_bib6","doi-asserted-by":"crossref","first-page":"R85","DOI":"10.1530\/EJE-16-1047","article-title":"Mechanisms in endocrinology: the multiple facets of GHRH\/GH\/IGF-I axis: lessons from lifetime, untreated, isolated GH deficiency due to a GHRH receptor gene mutation","volume":"177","author":"Aguiar-Oliveira","year":"2017","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.mce.2020.111003_bib7","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.1016\/S0022-3476(97)70008-8","article-title":"Risk of leukemia in children treated with human growth hormone: review and reanalysis","volume":"131","author":"Allen","year":"1997","journal-title":"J. Pediatr."},{"key":"10.1016\/j.mce.2020.111003_bib8","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1097\/IGC.0b013e318254011f","article-title":"BRCA1 is expressed in uterine serous carcinoma (USC) and controls insulin-like growth factor I receptor (IGF-IR) gene expression in USC cell lines","volume":"22","author":"Amichay","year":"2012","journal-title":"Int. J. Gynecol. Canc."},{"key":"10.1016\/j.mce.2020.111003_bib9","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1056\/NEJM198910123211501","article-title":"Laron dwarfism and mutations of the growth hormone-receptor gene","volume":"321","author":"Amselem","year":"1989","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.mce.2020.111003_bib10","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1016\/j.ejca.2011.09.014","article-title":"p53 Regulates insulin-like growth factor-I receptor gene expression in uterine serous carcinoma and predicts responsiveness to an insulin-like growth factor-I receptor-directed targeted therapy","volume":"48","author":"Attias-Geva","year":"2012","journal-title":"Eur. J. Canc."},{"key":"10.1016\/j.mce.2020.111003_bib11","doi-asserted-by":"crossref","first-page":"6304","DOI":"10.1158\/1078-0432.CCR-10-3336","article-title":"A phase I pharmacokinetic and pharmacodynamic study of dalotuzumab (MK-0646), an anti-insulin-like growth factor-1 receptor monoclonal antibody, in patients with advanced solid tumors","volume":"17","author":"Atzori","year":"2011","journal-title":"Clin. Canc. Res."},{"key":"10.1016\/j.mce.2020.111003_bib12","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.gde.2010.10.002","article-title":"New plays in the p53 theater","volume":"38","author":"Aylon","year":"2011","journal-title":"Curr. Opin. Genet. Dev."},{"key":"10.1016\/j.mce.2020.111003_bib13","first-page":"521","article-title":"Insulin-like growth factor binding proteins--an update","volume":"13","author":"Bach","year":"2015","journal-title":"Pediatr. Endocrinol. Rev."},{"key":"10.1016\/j.mce.2020.111003_bib14","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1038\/sj.bjc.6603632","article-title":"Absence of the common insulin-like growth factor-1 19-repeat allele is associated with early age at breast cancer diagnosis in multiparous women","volume":"96","author":"B\u00e5geman","year":"2007","journal-title":"Br. J. Canc."},{"key":"10.1016\/j.mce.2020.111003_bib15","first-page":"395","article-title":"Acromegaly and cancer risk: a cohort study in Sweden and Denmark","volume":"13","author":"Baris","year":"2002","journal-title":"Cancer Causes Conntrol"},{"key":"10.1016\/j.mce.2020.111003_bib16","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1002\/jcp.24217","article-title":"The decline and fall of the IGF-I receptor","volume":"28","author":"Baserga","year":"2013","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.mce.2020.111003_bib17","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/BF02778073","article-title":"The IGF-1 receptor and cancer","volume":"7","author":"Baserga","year":"1997","journal-title":"Endocrine"},{"key":"10.1016\/j.mce.2020.111003_bib18","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s12672-017-0292-7","article-title":"Growth hormone receptor knockdown sensitizes human melanoma cells to chemotherapy by attenuating expression of ABC drug efflux pumps","volume":"8","author":"Basu","year":"2017","journal-title":"Hormones Canc."},{"key":"10.1016\/j.mce.2020.111003_bib19","first-page":"827","article-title":"The effects of growth hormone on therapy resistance in cancer","volume":"2","author":"Basu","year":"2019","journal-title":"Cancer Drug Resist"},{"key":"10.1016\/j.mce.2020.111003_bib20","doi-asserted-by":"crossref","first-page":"R155","DOI":"10.1530\/EJE-18-0018","article-title":"Lessons from growth hormone receptor gene-disrupted mice: are there benefits of endocrine defects?","volume":"178","author":"Basu","year":"2018","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.mce.2020.111003_bib21","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1210\/me.2015-1157","article-title":"Were the IGF signaling inhibitors all bad?","volume":"29","author":"Beckwith","year":"2015","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.mce.2020.111003_bib22","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1210\/jc.2009-0178","article-title":"Long-term safety of recombinant human growth hormone in children","volume":"95","author":"Bell","year":"2010","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.mce.2020.111003_bib23","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1158\/1535-7163.MCT-08-1171","article-title":"AMG-479, a fully human anti-insulin-like growth factor receptor type I monoclonal antibody, inhibits the growth and survival of pancreatic carcinoma cells","volume":"8","author":"Beltran","year":"2009","journal-title":"Mol. Canc. Therapeut."},{"key":"10.1016\/j.mce.2020.111003_bib24","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/nrc3711","article-title":"Unravelling mechanisms of p53-mediated tumour suppression","volume":"14","author":"Bieging","year":"2014","journal-title":"Nat. Rev. Canc."},{"key":"10.1016\/j.mce.2020.111003_bib25","doi-asserted-by":"crossref","first-page":"R147","DOI":"10.1530\/EJE-16-0178","article-title":"Management of endocrine disease: acromegaly and cancer: an old debate revisited","volume":"175","author":"Boguszewski","year":"2016","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.mce.2020.111003_bib26","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1210\/er.2018-00166","article-title":"Growth hormone's links to cancer","volume":"40","author":"Boguszewski","year":"2019","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.mce.2020.111003_bib27","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.ghir.2019.11.004","article-title":"From dwarves to giants: south American's contribution to the history of growth hormone and related disorders","volume":"50","author":"Boguszewski","year":"2020","journal-title":"Growth Hormone IGF Res."},{"key":"10.1016\/j.mce.2020.111003_bib28","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1210\/mend-4-9-1386","article-title":"Cellular pattern of insulin-like growth factor I (IGF-I) and type I IGF receptor gene expression in early organogenesis: comparison with IGF-II gene expression","volume":"4","author":"Bondy","year":"1990","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.mce.2020.111003_bib29","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1530\/ERC-12-0042","article-title":"Autocrine human GH promotes radioresistance in mammary and endometrial carcinoma cells","volume":"19","author":"Bougen","year":"2012","journal-title":"Endocr. Relat. Canc."},{"key":"10.1016\/j.mce.2020.111003_bib30","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2014.00076","article-title":"The IGF hormonal network in endometrial cancer: functions, regulation, and targeting approaches","volume":"5","author":"Bruchim","year":"2014","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.mce.2020.111003_bib31","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1210\/en.2008-0608","article-title":"Autocrine human growth hormone promotes tumor angiogenesis in mammary carcinoma","volume":"150","author":"Brunet-Dunand","year":"2009","journal-title":"Endocrinology"},{"key":"10.1016\/j.mce.2020.111003_bib32","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1210\/jc.2011-1995","article-title":"Long-term mortality after recombinant growth hormone treatment for isolated growth hormone deficiency or childhood short stature: preliminary report of the French SAGhE study","volume":"97","author":"Carel","year":"2012","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.mce.2020.111003_bib33","article-title":"Autocrine human growth hormone promotes invasive and cancer stem cell-like behavior of hepatocellular carcinoma cells by STAT3 dependent inhibition of CLAUDIN-1 expression","volume":"18","author":"Chen","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.mce.2020.111003_bib34","doi-asserted-by":"crossref","first-page":"E3331","DOI":"10.1073\/pnas.1310589110","article-title":"Growth hormone is a cellular senescence target in pituitary and nonpituitary cells","volume":"110","author":"Chesnokova","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.mce.2020.111003_bib35","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1586\/eem.10.73","article-title":"Role of the growth hormone\u2013 IGF-1 axis in cancer","volume":"6","author":"Chhabra","year":"2011","journal-title":"Expet Rev. Endocrinol. Metabol."},{"key":"10.1016\/j.mce.2020.111003_bib36","doi-asserted-by":"crossref","first-page":"6364","DOI":"10.1158\/1078-0432.CCR-07-4879","article-title":"The type I insulin-like growth factor-I receptor pathway","volume":"14","author":"Chitnis","year":"2008","journal-title":"Clin. Canc. Res."},{"key":"10.1016\/j.mce.2020.111003_bib37","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1046\/j.1365-2362.1998.00247.x","article-title":"In vitro effects of growth hormone (GH) and insulin-like growth factor I and II (IGF-I and -II) on chromosome fragility and p53 protein expression in human lymphocytes","volume":"28","author":"Cianfarani","year":"1998","journal-title":"Eur. J. Clin. Invest."},{"key":"10.1016\/j.mce.2020.111003_bib38","doi-asserted-by":"crossref","first-page":"92","DOI":"10.6065\/apem.2019.24.2.92","article-title":"Risk of cancer in patients treated with recombinant human growth hormone in childhood","volume":"24","author":"Cianfarini","year":"2019","journal-title":"Ann. Ped. Endocrinol. Metab."},{"key":"10.1016\/j.mce.2020.111003_bib39","doi-asserted-by":"crossref","first-page":"148","DOI":"10.3389\/fendo.2017.00148","article-title":"Identification of BRCA1 as a potential biomarker for insulin-like growth factor-1 receptor targeted therapy in breast cancer","volume":"8","author":"Cohen-Sinai","year":"2017","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.mce.2020.111003_bib40","doi-asserted-by":"crossref","first-page":"13331","DOI":"10.1073\/pnas.0600181104","article-title":"Nuclear targeting of the growth hormone receptor results in dysregulation of cell proliferation and tumorigenesis","volume":"104","author":"Conway-Campbell","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.mce.2020.111003_bib41","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1002\/cbin.10747","article-title":"Growth hormone modulates in vitro endothelial cell migration and formation of capillary-like structures","volume":"41","author":"de Lima","year":"2017","journal-title":"Cell Biol. Int."},{"key":"10.1016\/j.mce.2020.111003_bib42","doi-asserted-by":"crossref","first-page":"824","DOI":"10.2353\/ajpath.2008.071005","article-title":"Paracrine overexpression of insulin-like growth factor-1 enhances mammary tumorigenesis in vivo","volume":"173","author":"de Ostrovich","year":"2008","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.mce.2020.111003_bib43","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3389\/fendo.2018.00035","article-title":"The growth hormone receptor: mechanism of receptor activation, cell signaling, and physiological aspects","volume":"9","author":"Dehkhoda","year":"2018","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.mce.2020.111003_bib44","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1210\/jc.2007-1191","article-title":"Mortality in acromegaly: a metaanalysis","volume":"93","author":"Dekkers","year":"2008","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.mce.2020.111003_bib45","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/S0140-6736(94)91578-4","article-title":"Risks of cancer in BRCA1-mutation carriers. Breast cancer linkage consortium","volume":"343","author":"Ford","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.mce.2020.111003_bib46","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1126\/science.7939630","article-title":"BRCA1 mutations in primary breast and ovarian carcinomas","volume":"266","author":"Futreal","year":"1994","journal-title":"Science"},{"key":"10.1016\/j.mce.2020.111003_bib47","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1210\/er.2018-00115","article-title":"Systemic complications of acromegaly and the impact of the current treatment landscape: an update","volume":"40","author":"Gadelha","year":"2019","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.mce.2020.111003_bib48","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1016\/S0002-9440(10)64071-0","article-title":"Growth hormone receptor is expressed in human breast cancer","volume":"158","author":"Gebre-Medhin","year":"2001","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.mce.2020.111003_bib49","first-page":"345","article-title":"A prospective study of plasma insulin-like growth factor-1 and binding protein-3 and risk of colorectal neoplasia in women","volume":"9","author":"Giovannucci","year":"2000","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"10.1016\/j.mce.2020.111003_bib50","first-page":"5278","article-title":"Increased expression of insulin-like growth factor I receptor in malignant cells expressing aberrant p53: functional impact","volume":"60","author":"Girnita","year":"2000","journal-title":"Canc. Res."},{"key":"10.1016\/j.mce.2020.111003_bib51","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1007\/s00018-013-1514-y","article-title":"Something old, something new and something borrowed: emerging paradigm of insulin-like growth factor type 1 receptor signaling regulation","volume":"71","author":"Girnita","year":"2014","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.mce.2020.111003_bib52","doi-asserted-by":"crossref","first-page":"8083","DOI":"10.1073\/pnas.86.20.8083","article-title":"Characterization of the human growth hormone receptor gene and demonstration of a partial gene deletion in two patients with Laron-type dwarfism","volume":"86","author":"Godowski","year":"1989","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.mce.2020.111003_bib53","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3001845","article-title":"Growth hormone receptor deficiency is associated with a major reduction in pro-aging signaling, cancer, and diabetes in humans","volume":"3","author":"Guevara-Aguirre","year":"2011","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.mce.2020.111003_bib54","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1016\/S0140-6736(97)10384-1","article-title":"Circulating concentrations of insulin-like growth factor-I and risk of breast cancer","volume":"351","author":"Hankinson","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.mce.2020.111003_bib55","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1056\/NEJM199310283291807","article-title":"Clinical implications of the p53 tumor suppressor gene","volume":"329","author":"Harris","year":"1993","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.mce.2020.111003_bib56","first-page":"2942","article-title":"Expression of the type 1 insulin-like growth factor receptor is up-regulated in primary prostate cancer and commonly persists in metastatic disease","volume":"62","author":"Hellawell","year":"2002","journal-title":"Canc. Res."},{"issue":"Suppl. 5","key":"10.1016\/j.mce.2020.111003_bib57","first-page":"166","article-title":"Excess mortality in acromegaly","volume":"68","author":"Holdaway","year":"2008","journal-title":"Horm. Res."},{"key":"10.1016\/j.mce.2020.111003_bib58","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1677\/ERC-06-0075","article-title":"Intratumoral IGF-I protein expression is selectively upregulated in breast cancer patients with BRCA1\/2 mutations","volume":"14","author":"Hudelist","year":"2007","journal-title":"Endocr. Relat. Canc."},{"key":"10.1016\/j.mce.2020.111003_bib59","doi-asserted-by":"crossref","first-page":"3474","DOI":"10.1074\/jbc.M211606200","article-title":"WT1-p53 interactions in IGF-I receptor gene regulation","volume":"278","author":"Idelman","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.mce.2020.111003_bib60","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1126\/science.2047879","article-title":"Identification of p53 as a sequence-specific DNA-binding protein","volume":"252","author":"Kern","year":"1991","journal-title":"Science"},{"key":"10.1016\/j.mce.2020.111003_bib61","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1530\/ERC-16-0054","article-title":"Identification of signaling pathways associated with cancer protection in Laron syndrome","volume":"23","author":"Lapkina-Gendler","year":"2016","journal-title":"Endocr. Relat. Canc."},{"key":"10.1016\/j.mce.2020.111003_bib62","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1210\/jc.2003-031033","article-title":"Extensive personal experience. Laron syndrome (primary growth hormone resistance or insensitivity): the personal experience 1958-2003","volume":"89","author":"Laron","year":"2004","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.mce.2020.111003_bib63","first-page":"364","article-title":"Growth hormone therapy: emerging dilemmas","volume":"8","author":"Laron","year":"2011","journal-title":"Pediatr. Endocrinol. Rev."},{"key":"10.1016\/j.mce.2020.111003_bib64","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.mrrev.2016.08.002","article-title":"IGF-I deficiency, longevity and cancer protection of patients with Laron syndrome","volume":"772","author":"Laron","year":"2017","journal-title":"Mutat. Res. Rev. Mutat. Res."},{"key":"10.1016\/j.mce.2020.111003_bib65","first-page":"152","article-title":"Genetic pituitary dwarfism with high serum concentration of growth hormone-a new inborn error of metabolism?","volume":"2","author":"Laron","year":"1966","journal-title":"Isr. J. Med. Sci."},{"key":"10.1016\/j.mce.2020.111003_bib66","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.ygcen.2015.06.011","article-title":"Growth hormone and cancer: GH production and action in glioma?","volume":"220","author":"Lea","year":"2015","journal-title":"Gen. Comp. Endocrinol."},{"key":"10.1016\/j.mce.2020.111003_bib67","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1530\/EJE-18-0176","article-title":"Characterization of an activating R1353H insulin-like growth factor 1 receptor variant in a male with extreme tall height","volume":"179","author":"Lin","year":"2018","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.mce.2020.111003_bib68","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1093\/jnci\/91.7.620","article-title":"Prospective study of colorectal cancer risk in men and plasma levels of insulin-like growth factor (IGF)-I and IGF-binding protein-3","volume":"91","author":"Ma","year":"1999","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.mce.2020.111003_bib69","doi-asserted-by":"crossref","first-page":"2897","DOI":"10.1158\/1078-0432.CCR-15-2218","article-title":"Phase I dose-escalation study of Linsitinib (OSI-906) and Erlotinib in patients with advanced solid tumors","volume":"22","author":"Macaulay","year":"2016","journal-title":"Clin. Canc. Res."},{"key":"10.1016\/j.mce.2020.111003_bib70","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1210\/jc.2011-3363","article-title":"Reports of increased mortality and GH: will this affect current clinical practice?","volume":"97","author":"Malozowski","year":"2012","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.mce.2020.111003_bib71","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1002\/(SICI)1097-0215(19990209)80:4<523::AID-IJC7>3.0.CO;2-C","article-title":"Leptin in relation to carcinoma in situ of the breast: a study of pre-menopausal cases and controls","volume":"80","author":"Mantzoros","year":"1999","journal-title":"Int. J. Canc."},{"key":"10.1016\/j.mce.2020.111003_bib72","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1677\/joe.1.07016","article-title":"Estrogen receptor regulates insulin-like growth factor-I receptor gene expression in breast tumor cells: involvement of transcription factor Sp1","volume":"191","author":"Maor","year":"2006","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.mce.2020.111003_bib73","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1055\/s-2007-970415","article-title":"Insulin-like growth factor-I controls BRCA1 gene expression through activation of transcription factor Sp1","volume":"39","author":"Maor","year":"2007","journal-title":"Horm. Metab. Res."},{"key":"10.1016\/j.mce.2020.111003_bib74","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.canlet.2007.07.019","article-title":"Elevated insulin-like growth factor-I receptor (IGF-IR) levels in primary breast tumors associated with BRCA1 mutations","volume":"257","author":"Maor","year":"2007","journal-title":"Canc. Lett."},{"key":"10.1016\/j.mce.2020.111003_bib75","doi-asserted-by":"crossref","first-page":"2558","DOI":"10.1056\/NEJMra062453","article-title":"Acromegaly","volume":"355","author":"Melmed","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.mce.2020.111003_bib76","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1038\/s41574-018-0058-5","article-title":"A consensus statement on acromegaly therapeutic outcomes","volume":"14","author":"Melmed","year":"2018","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.mce.2020.111003_bib77","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1126\/science.7545954","article-title":"A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1","volume":"266","author":"Miki","year":"1994","journal-title":"Science"},{"key":"10.1016\/j.mce.2020.111003_bib78","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1038\/cdd.2013.9","article-title":"p53 is required for brown adipogenic differentiation and has a protective role against diet-induced obesity","volume":"20","author":"Molchadsky","year":"2013","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.mce.2020.111003_bib79","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1038\/sj.bjc.6605767","article-title":"The insulin-like growth factor-I receptor inhibitor figitumumab (CP-751,871) in combination with docetaxel in patients with advanced solid tumours: results of a phase Ib dose-escalation, open-label study","volume":"103","author":"Molife","year":"2010","journal-title":"Br. J. Canc."},{"key":"10.1016\/j.mce.2020.111003_bib80","doi-asserted-by":"crossref","first-page":"3680","DOI":"10.1158\/0008-5472.CAN-07-6271","article-title":"Reduced susceptibility to two-stage skin carcinogenesis in mice with low circulating insulin-like growth factor-I levels","volume":"68","author":"Moore","year":"2008","journal-title":"Canc. Res."},{"key":"10.1016\/j.mce.2020.111003_bib81","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.annonc.2020.01.066","article-title":"Insulin-like growth factor-1, insulin-like growth factor-binding protein-3, and breast cancer risk: observational and mendelian randomization analyses with ~430 000 women","volume":"31","author":"Murphy","year":"2020","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.mce.2020.111003_bib82","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1073\/pnas.1715930115","article-title":"Identification of thioredoxin-interacting protein (TXNIP) as a downstream target for IGF1 action","volume":"115","author":"Nagaraj","year":"2018","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.mce.2020.111003_bib83","first-page":"388","article-title":"The p53-family members p63 and p73 inhibit insulin-like growth factor-I receptor gene expression in colon cancer cells, Growth Hormone","volume":"15","author":"Nahor","year":"2005","journal-title":"IGF Res"},{"key":"10.1016\/j.mce.2020.111003_bib84","doi-asserted-by":"crossref","first-page":"3169","DOI":"10.1096\/fasebj.6.13.1397838","article-title":"p53: the ultimate tumor suppressor gene?","volume":"6","author":"Oren","year":"1992","journal-title":"Faseb. J."},{"key":"10.1016\/j.mce.2020.111003_bib85","doi-asserted-by":"crossref","first-page":"3909","DOI":"10.1210\/en.2008-0286","article-title":"Autocrine human growth hormone stimulates oncogenicity of endometrial carcinoma cells","volume":"149","author":"Pandey","year":"2008","journal-title":"Endocrinology"},{"key":"10.1016\/j.mce.2020.111003_bib86","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1210\/jc.2013-4159","article-title":"Growth hormone exposure as a risk factor for the development of subsequent neoplasms of the central nervous system: a report from the childhood cancer survivor study","volume":"99","author":"Patterson","year":"2014","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.mce.2020.111003_bib87","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1002\/1097-0142(195901\/02)12:1<85::AID-CNCR2820120114>3.0.CO;2-G","article-title":"Results of hypophysectomy in the treatment of metastatic mammary carcinoma","volume":"12","author":"Pearson","year":"1959","journal-title":"Cancer"},{"key":"10.1016\/j.mce.2020.111003_bib88","doi-asserted-by":"crossref","first-page":"27315","DOI":"10.1016\/S0021-9258(18)46987-6","article-title":"C phosphorylation and activation of the IGF-I receptor in src-transformed cells","volume":"269","author":"Peterson","year":"1994","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.mce.2020.111003_bib89","doi-asserted-by":"crossref","first-page":"3465","DOI":"10.1002\/cam4.1602","article-title":"Increased risk of bone tumors after growth hormone treatment in childhood: a population-based cohort study in France","volume":"7","author":"Poidvin","year":"2018","journal-title":"Cancer Med"},{"key":"10.1016\/j.mce.2020.111003_bib90","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/nrc3215","article-title":"The insulin and insulin-like growth factor receptor family in neoplasia: an update","volume":"12","author":"Pollak","year":"2012","journal-title":"Nat. Rev. Canc."},{"key":"10.1016\/j.mce.2020.111003_bib91","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1128\/MCB.17.3.1084","article-title":"The insulin-like growth factor I receptor as a physiologically relevant target of p53 in apoptosis caused by interleukin-3 withdrawal","volume":"17","author":"Prisco","year":"1997","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.mce.2020.111003_bib92","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1210\/jc.2015-1002","article-title":"Risk of neoplasia in pediatric patients receiving growth hormone therapy--A report from the Pediatric Endocrine Society Drug and Therapeutics Committee","volume":"100","author":"Raman","year":"2015","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.mce.2020.111003_bib93","first-page":"5997","article-title":"The protooncogene c-myb increases the expression of insulin-like growth factor I and insulin-like growth factor I receptor messenger RNAs by a transcriptional mechanism","volume":"51","author":"Reiss","year":"1991","journal-title":"Canc. Res."},{"key":"10.1016\/j.mce.2020.111003_bib94","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1016\/S0140-6736(04)16044-3","article-title":"Insulin-like growth factor-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis","volume":"363","author":"Renehan","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.mce.2020.111003_bib95","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1677\/erc.1.01150","article-title":"IGF-I, IGFBP-3 and breast cancer risk in women: the European Prospective Investigation into Cancer and Nutrition (EPIC)","volume":"13","author":"Rinaldi","year":"2006","journal-title":"Endocr. Relat. Canc."},{"key":"10.1016\/j.mce.2020.111003_bib96","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1530\/ERC-16-0106","article-title":"Mortality in acromegaly: a 20-year follow-up study","volume":"23","author":"Ritvonen","year":"2016","journal-title":"Endocr. Relat. Canc."},{"key":"10.1016\/j.mce.2020.111003_bib97","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.mce.2006.03.018","article-title":"Transcriptional regulation of the insulin-like growth factor-1 receptor in breast cancer","volume":"252","author":"Sarfstein","year":"2006","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.mce.2020.111003_bib98","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.mce.2010.04.017","article-title":"Differential regulation of IGF1-R gene transcription by wild type and mutant androgen receptor in prostate cancer cells","volume":"323","author":"Schayek","year":"2010","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.mce.2020.111003_bib99","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1002\/1097-0215(20001120)89:6<506::AID-IJC7>3.0.CO;2-F","article-title":"Down-regulation of insulin-like growth factor-I receptor and insulin receptor substrate-1 expression in advanced human breast cancer","volume":"89","author":"Schnarr","year":"2000","journal-title":"Int. J. Canc."},{"key":"10.1016\/j.mce.2020.111003_bib100","doi-asserted-by":"crossref","first-page":"2627","DOI":"10.1158\/0008-5472.CAN-03-0846","article-title":"The tumor suppressor p53 down-regulates glucose transporters GLUT1 and GLUT4 gene expression","volume":"64","author":"Schwartzenberg-Bar-Yoseph","year":"2004","journal-title":"Canc. Res."},{"key":"10.1016\/j.mce.2020.111003_bib101","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1097\/CCO.0b013e328302edab","article-title":"Targeting insulin-like growth factor 1 receptor in sarcomas","volume":"20","author":"Scotlandi","year":"2008","journal-title":"Curr. Opin. Oncol."},{"key":"10.1016\/j.mce.2020.111003_bib102","first-page":"3604","article-title":"Effect of a null mutation of the insulin-like growth factor I receptor gene on growth and transformation of mouse embryo fibroblasts","volume":"14","author":"Sell","year":"1994","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.mce.2020.111003_bib103","doi-asserted-by":"crossref","first-page":"11217","DOI":"10.1073\/pnas.90.23.11217","article-title":"Simian virus 40 large tumor antigen is unable to transform mouse embryonic fibroblasts lacking type 1 insulin-like growth factor receptor","volume":"90","author":"Sell","year":"1993","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.mce.2020.111003_bib104","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.ghir.2006.10.007","article-title":"Patients with congenital deficiency of IGF-I seem protected from the development of malignancies: a preliminary report","volume":"17","author":"Shevah","year":"2007","journal-title":"Growth Hormone IGF Res."},{"key":"10.1016\/j.mce.2020.111003_bib105","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1054\/bjoc.2001.1961","article-title":"Insulin-like growth factor-I and prostate cancer: a meta-analysis","volume":"85","author":"Shi","year":"2001","journal-title":"Br. J. Canc."},{"key":"10.1016\/j.mce.2020.111003_bib106","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1002\/ijc.20233","article-title":"IGF-I and breast cancer: a meta analysis","volume":"111","author":"Shi","year":"2004","journal-title":"Int. J. Canc."},{"key":"10.1016\/j.mce.2020.111003_bib107","doi-asserted-by":"crossref","first-page":"7151","DOI":"10.1158\/0008-5472.CAN-05-4570","article-title":"Absence of the full-length breast cancer-associated gene-1 leads to increased expression of insulin-like growth factor signaling axis members","volume":"66","author":"Shukla","year":"2006","journal-title":"Canc. Res."},{"key":"10.1016\/j.mce.2020.111003_bib108","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1038\/s41416-019-0677-1","article-title":"Type 1 IGF receptor associates with adverse outcome and cellular radioresistance in pediatric high-grade glioma","volume":"122","author":"Simpson","year":"2020","journal-title":"Br. J. Canc."},{"issue":"Suppl. 3","key":"10.1016\/j.mce.2020.111003_bib109","first-page":"30","article-title":"Growth hormone treatment: cancer risk","volume":"62","author":"Sklar","year":"2004","journal-title":"Horm. Res."},{"key":"10.1016\/j.mce.2020.111003_bib110","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.18632\/oncotarget.27566","article-title":"Proteomic analysis of combined IGF1 receptor targeted therapy and chemotherapy identifies signatures associated with survival in breast cancer patients","volume":"11","author":"Sinai-Livne","year":"2020","journal-title":"Oncotarget"},{"key":"10.1016\/j.mce.2020.111003_bib111","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.ghir.2017.11.004","article-title":"Differential expression of IGFBPs in Laron syndrome-derived lymphoblastoid cell lines: potential correlation with reduced cancer incidence","volume":"39","author":"Somri","year":"2018","journal-title":"Growth Hormone IGF Res."},{"key":"10.1016\/j.mce.2020.111003_bib112","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1159\/000182571","article-title":"Leukemia in growth-hormone-treated patients: An update","volume":"38","author":"Stahnke","year":"1992","journal-title":"Horm. Res."},{"key":"10.1016\/j.mce.2020.111003_bib113","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1530\/EJE-10-0859","article-title":"Congenital IGF1 deficiency tends to confer protection against post-natal development of malignancies","volume":"164","author":"Steuerman","year":"2011","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.mce.2020.111003_bib114","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.ghir.2015.06.006","article-title":"Reviewing the safety of GH replacement therapy in adults","volume":"25","author":"Stochholm","year":"2015","journal-title":"Growth Hormone IGF Res."},{"key":"10.1016\/j.mce.2020.111003_bib115","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1111\/cen.13502","article-title":"Long-term safety of growth hormone-A combined registry analysis","volume":"88","author":"Stochholm","year":"2018","journal-title":"Clin. Endocrinol."},{"key":"10.1016\/j.mce.2020.111003_bib116","doi-asserted-by":"crossref","first-page":"e117","DOI":"10.1038\/emm.2014.61","article-title":"Growth hormone receptor inhibition decreases the growth and metastasis of pancreatic ductal adenocarcinoma","volume":"46","author":"Subramani","year":"2014","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.mce.2020.111003_bib117","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.bbrc.2013.10.023","article-title":"Human metastatic melanoma cell lines express high levels of growth hormone receptor and respond to GH treatment","volume":"441","author":"Sustarsic","year":"2013","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.mce.2020.111003_bib118","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1007\/s11102-016-0744-z","article-title":"Complications of acromegaly: thyroid and colon","volume":"20","author":"Tirosh","year":"2017","journal-title":"Pituitary"},{"key":"10.1016\/j.mce.2020.111003_bib119","doi-asserted-by":"crossref","first-page":"6152","DOI":"10.1038\/sj.onc.1203974","article-title":"BRCA1 and cell signaling","volume":"19","author":"Wang","year":"2000","journal-title":"Oncogene"},{"key":"10.1016\/j.mce.2020.111003_bib120","doi-asserted-by":"crossref","first-page":"5188","DOI":"10.1210\/en.2005-0607","article-title":"Disruption of growth hormone signaling retards early stages of prostate carcinogenesis in the C3(1)\/T antigen mouse","volume":"146","author":"Wang","year":"2005","journal-title":"Endocrinology"},{"key":"10.1016\/j.mce.2020.111003_bib121","doi-asserted-by":"crossref","first-page":"14992","DOI":"10.1073\/pnas.0406396101","article-title":"The oncogenic potential of autocrine human growth hormone in breast cancer","volume":"101","author":"Waters","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.mce.2020.111003_bib122","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.mce.2004.03.004","article-title":"Growth hormone (GH) receptors in prostate cancer: gene expression in human tissues and cell lines and characterization, GH signaling and androgen receptor regulation in LNCaP cells","volume":"220","author":"Weiss-Messer","year":"2004","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.mce.2020.111003_bib123","first-page":"2","article-title":"The pathophysiological significance of IGF-I receptor overexpression: new insights","volume":"7","author":"Werner","year":"2009","journal-title":"Pediatr. Endocrinol. Rev."},{"key":"10.1016\/j.mce.2020.111003_bib124","doi-asserted-by":"crossref","first-page":"2703","DOI":"10.1038\/onc.2011.447","article-title":"Tumor suppressors govern insulin-like growth factor signaling pathways: implications in metabolism and cancer","volume":"31","author":"Werner","year":"2012","journal-title":"Oncogene"},{"key":"10.1016\/j.mce.2020.111003_bib125","doi-asserted-by":"crossref","first-page":"e537","DOI":"10.1016\/S1470-2045(12)70362-5","article-title":"IGF-1 and BRCA1 signalling pathways in familial cancer","volume":"13","author":"Werner","year":"2012","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.mce.2020.111003_bib126","doi-asserted-by":"crossref","first-page":"8318","DOI":"10.1073\/pnas.93.16.8318","article-title":"Wild type and mutant p53 differentially regulate transcription of the insulin-like growth factor I receptor gene","volume":"93","author":"Werner","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.mce.2020.111003_bib127","first-page":"6","article-title":"Fifty years on: new lessons from Laron syndrome","volume":"19","author":"Werner","year":"2017","journal-title":"Isr. Med. Assoc. J."},{"key":"10.1016\/j.mce.2020.111003_bib128","doi-asserted-by":"crossref","DOI":"10.4081\/tmr.6657","article-title":"Genome-wide profiling of congenital IGF1 deficient patients: translational implications in cancer prevention and metabolism","volume":"1","author":"Werner","year":"2017","journal-title":"Transl. Med. Rep."},{"key":"10.1016\/j.mce.2020.111003_bib129","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s12943-018-0807-z","article-title":"Oncogenic fusion proteins adopt the insulin-like growth factor signaling pathway","volume":"17","author":"Werner","year":"2018","journal-title":"Mol. Canc."},{"key":"10.1016\/j.mce.2020.111003_bib130","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.ghir.2014.03.006","article-title":"Transcriptional and epigenetic control of IGF1R gene expression: implications in metabolism and cancer","volume":"24","author":"Werner","year":"2014","journal-title":"Growth Hormone IGF Res."},{"key":"10.1016\/j.mce.2020.111003_bib131","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1080\/13543784.2019.1694660","article-title":"Investigational IGF1R inhibitors in early stage clinical trials for cancer therapy","volume":"28","author":"Werner","year":"2019","journal-title":"Expet Opin. Invest. Drugs"},{"key":"10.1016\/j.mce.2020.111003_bib132","doi-asserted-by":"crossref","first-page":"159","DOI":"10.3389\/fonc.2016.00159","article-title":"Insulin-like growth factor 1 signaling axis meets p53 genome protection pathways","volume":"6","author":"Werner","year":"2016","journal-title":"Front. Oncol."},{"key":"10.1016\/j.mce.2020.111003_bib133","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.jss.2007.03.056","article-title":"Growth hormone receptor expression is up-regulated during tumorigenesis of human colorectal cancer","volume":"143","author":"Wu","year":"2007","journal-title":"J. Surg. Res."},{"key":"10.1016\/j.mce.2020.111003_bib134","doi-asserted-by":"crossref","first-page":"486","DOI":"10.3892\/mmr.2014.2185","article-title":"Growth hormone protects colorectal cancer cells from radiation by improving the ability of DNA damage repair","volume":"10","author":"Wu","year":"2014","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.mce.2020.111003_bib135","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1023\/A:1006189906896","article-title":"BRCA1 and BRCA2 in breast cancer","volume":"54","author":"Yang","year":"1999","journal-title":"Breast Canc. Res. Treat."}],"container-title":["Molecular and Cellular Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303720720303051?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303720720303051?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T14:18:17Z","timestamp":1759587497000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0303720720303051"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":135,"alternative-id":["S0303720720303051"],"URL":"https:\/\/doi.org\/10.1016\/j.mce.2020.111003","relation":{},"ISSN":["0303-7207"],"issn-type":[{"value":"0303-7207","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Role of the GH-IGF1 system in progression of cancer","name":"articletitle","label":"Article Title"},{"value":"Molecular and Cellular Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mce.2020.111003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"111003"}}